Dr. Robert Menuet has joined Cardiovascular Institute of the South as a staff cardiologist. Menuet is seeing patients at the Heart and Vascular Institute at Opelousas General at 1233 Wayne Gilmore Circle, Ste. 450. He is board certified in internal medicine and has served the Opelousas community for three years. In 2000, Menuet received his medical degree from LSU School of Medicine. He completed his internal medicine residency at the University of Texas Medical Branch in Galveston, Texas, and his cardiology fellowship at Ochsner Clinic Foundation in New Orleans.

Dr. Michelle R. Stutes has joined Acadiana Women’s Health Group, an obstetrics and gynecology practice based at Women’s and Children’s Hospital. Stutes previously was a clinical instructor at Louisiana State University Health Sciences Center Department of Obstetrics and Gynecology. She completed her four-year residency with LSUHSC in June 2007. A UL Lafayette and Lafayette High School graduate, Stutes earned her medical doctorate from LSU School of Medicine. Acadiana Women’s Health Group is comprised of 11 OB/GYNs and two nurse practitioners. The group also provides laser services for hair removal and skin rejuvenation, tattoo removal, bone density testing, ultrasounds and laparoscopic hysterectomies.

Huntington’s Disease Society of America is calling for local support for the national walk initiative, Team Hope Walk for HD. Team Hope Walk for HD is a national movement to bring awareness and research funds to HD. The Lafayette walk will take place Oct. 17, with registration at 1 p.m. and the walk beginning at 2 at Girard Park, 500 Girard Park Drive. Registration and an after party will take place at the big pavilion, and the walk will be around the Girard Park track. Walkers will raise money from the community in support of HD research. Team Hope Walk for HD is still recruiting sponsors and teams for the event. To register a team to walk, visit www.firstgiving.com/HDSATeamHope. For sponsorship or other information, contact Amy Vollman at (337) 453-3162, This email address is being protected from spambots. You need JavaScript enabled to view it. ; or Kelly Spisak at (337) 354-9080 or This email address is being protected from spambots. You need JavaScript enabled to view it. . HD is a devastating, hereditary, degenerative brain disorder for which there is no effective treatment or cure. HD slowly diminishes the affected individual’s ability to walk, think, talk and reason. Eventually, the person with HD becomes totally dependent upon others for his or her care. The disease is now recognized as one of the more common genetic disorders. More than a quarter of a million Americans have HD or are “at risk” of inheriting the disease from an affected parent.


To post a comment, please log into your IND account. If you do not have an account, click the "register" button to create one. Facebook comments can be used as an alternative to creating an account at theIND.com.

The ABiz Entrepreneur of the Year Symposium
Entrepreneur-Symposium14 315x178
the Grid!


LA LA Land

Read the Flipping Paper!

Click Here for the Entire Print Version of
IND Monthly